A smart polymer stabilized liquid crystal (PSLC) thin film with temperature-controllable light transmittance was prepared based on a smectic-A (SmA)–chiral nematic (N*) phase transition, and then the effect of the composition and the preparation condition of the PSLC film on its thermo-optical (T-O) characteristics has been investigated in detail. Within the temperature range of the SmA phase, the PSLC shows a strong opaque state due to the focal conic alignment of liquid crystal (LC) molecules, while the film exhibits a transparent state result from the parallel alignment of N* phase LC molecules at a higher temperature. Importantly, the PSLC films with different temperature of phase transition and contrast ratio can be prepared by changing the composition of photo-polymerizable monomer/LC/chiral dopant. According to the competition between the polymerization of the curable monomers and the diffusion of LC molecules, the ultraviolet (UV) curing surrounding temperature and the intensity of UV irradiation play a critical role in tuning the size of the polymer network meshes, which in turn influence the contrast ratio and the switching speed of the film. Our observations are expected to pave the way for preparing smart PSLC thin films for applications in areas of smart windows, thermo-detectors and other information recording devices.
Coronaviruses are viruses whose particles look like crowns. SARS-CoV-2 is the seventh member of the human coronavirus family to cause COVID-19 which is regarded as a once-in-a-century pandemic worldwide. It holds has the characteristics of a pandemic, which has broy -55ught many serious negative impacts to human beings. It may take time for humans to fight the pandemic. In addition to humans, SARS-CoV-2 also infects animals such as cats. This review introduces the origins, structures, pathogenic mechanisms, characteristics of transmission, detection and diagnosis, evolution and variation of SARS-CoV-2. We summarized the clinical characteristics, the strategies for treatment and prevention of COVID-19, and analyzed the problems and challenges we face.
Background and Aims. Histone deacetylase 1 (HDAC1) codes a protein that is a component of the histone deacetylase complex. The abnormal expression of HDAC1 is strongly correlated with cell proliferation, differentiation, transcription, and translation. Through continuous screening of genes associated with changes in lung adenocarcinoma (LUAD), gene networks are formed to explore tumor pathogenesis and new therapeutic targets. Methods. We evaluated HDAC1 gene survival analysis and its expression of LUAD using relevant websites and databases (TCGA and GEO databases). Through data mining, we determined the frequency and type of HDAC1 mutation, obtained the relevant heat map of the gene interaction network, completed the analysis of gene ontology and function enrichment, and understood the pharmaceutic of HDAC1. Results. We found that HDAC1 expression was associated with the prognosis of patients with LUAD. In gene expression analysis, HDAC1 was highly expressed in LUAD, and the HDAC1 interaction gene network (MARCKSL, eIF3I) was closely related to cellular gene expression. Functional network analysis shows that the expression of HDAC1 is related to the monitoring point of the G1-S phase of the cell cycle and the activation of the Notch signaling pathway (CSL transcription factor), which is involved in the process of cell proliferation and differentiation and gene expression associated with new therapeutic targets. Conclusion. Our data revealed the expression and potential regulatory factors of HDAC1 in LUAD of data mining, which laid a foundation for the study of the occurrence, development, and treatment of HDAC1 in LUAD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.